Mozobil 20 mg ml solution for injection
- Name:
Mozobil 20 mg ml solution for injection
- Company:
Sanofi Genzyme
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 17/11/20

Click on this link to Download PDF directly
Sanofi Genzyme
Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 17 November 2020 PIL
Reasons for updating
- Improved presentation of PIL
Updated on 17 November 2020 PIL
Reasons for updating
- Improved presentation of PIL
Updated on 16 October 2020 PIL
Reasons for updating
- Change to section 6 - what the product contains
- Change to section 6 - what the product looks like and pack contents
- Change to section 6 - marketing authorisation holder
- Change to section 6 - marketing authorisation number
- Change to section 6 - manufacturer
Updated on 23 April 2020 PIL
Reasons for updating
- Improved presentation of PIL
Updated on 20 February 2020 PIL
Reasons for updating
- Change to section 6 - manufacturer
Updated on 13 June 2019 PIL
Reasons for updating
- Change to section 1 - what the product is used for
- Change to section 3 - use in children/adolescents
- Change to section 3 - how to take/use
Updated on 22 May 2019 SPC
Reasons for updating
- Change to section 4.1 - Therapeutic indications
- Change to section 4.2 - Posology and method of administration
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 5.3 - Preclinical safety data
- Change to section 7 - Marketing authorisation holder
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Sections 4.1, 4.2, 4.8, 5.1, 5.2, 5.3, 7.
- Extension of indication to paediatric patients 1-18 years
Updated on 14 January 2019 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
Updated on 14 January 2019 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
United Kingdom
Yellow Card Scheme
Website: www.mhra.gov.uk/yellowcard
or search for MHRA Yellow Card in the Google Play or Apple App Store.
7. MARKETING AUTHORISATION HOLDER
Genzyme Europe B.V., Paasheuvelweg 25, 1105 BP Amsterdam, The Netherlands
Updated on 22 November 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 22 November 2017 PIL
Reasons for updating
- Improved presentation of PIL
Updated on 26 October 2017 PIL
Reasons for updating
- New PIL for medicines.ie